Company intelligence / Profile preview

JEM Research Institute

Lake Worth, Florida, United Statesjemri.net ↗

Ownership: Private
Development stage: Other

Overview

JEM Research Institute operates as a leading clinical research site specializing in the implementation and management of clinical trials for new treatments in CNS disorders—especially Alzheimer’s disease—and other therapeutic areas. The institute has conducted over 200 clinical trials since its founding and was acquired by Headlands Research in July 2020 to expand capabilities in CNS research and increase diversity/inclusion in aging population studies. Its board-certified neurologist founders are recognized key opinion leaders.

Therapeutic areas: OtherNeurology
Modalities: Small moleculeBiologicMonoclonal antibody
Industry: Contract Research Organization

Partnerships

Pharmaceutical companies sponsoring CNS and Alzheimer’s disease trialsHeadlands Research network

Beyond the preview

Go deeper on JEM Research Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on JEM Research Institute.

Explore the full profile